iShares Nasdaq Profile

105.89
USD 1.46  1.36%
35%
17%

iShares Nasdaq Summary

iShares Nasdaq Biotechnology ETF [IBB] is traded in USA and was established on April 20, 2018. The fund is classified under Sector category within Blackrock family. iShares Nasdaq Biotechnology ETF currently have 9.08 B in assets under management (AUM). , while the total return for the last 3 years was -2.13%.
Check iShares Nasdaq Probability Of Bankruptcy

Geographic Allocation (%)

Sector Allocation (%)

iShares Nasdaq Biote Currency Exposure (%)

 % of ETF 
      Currency 

Target Price Odds Analysis

Below OddsHorizonTargetAbove Odds
about 22.2%30 days 105.89  about 77.54%
Based on normal probability distribution, the odds of iShares Nasdaq to move above current price in 30 days from now is about 77.54% (This iShares Nasdaq Biotechnology ETF probability density function shows the probability of iShares Nasdaq Etf to fall within a particular range of prices over 30 days) .

Top Holders

iShares Nasdaq Biote Risk Profiles

iShares Nasdaq Biote Technical Analysis

Transformation
The output start index for this execution was zero with a total number of output elements of thirty-nine. iShares Nasdaq Biote Inverse Tangent Over Price Movement function is an inverse trigonometric method to describe iShares Nasdaq price patterns. View also all equity analysis or get more info about inverse tangent over price movement math transform indicator.

Key Fundamentals

iShares Nasdaq Against Markets

Current Ratings

iShares Nasdaq 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
0 
Chance of
Financial Distress (0 to 100%)
< 2% 
Equity ratings for iShares Nasdaq Biotechnology ETF are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
The investment seeks to track the investment results of the NASDAQ Biotechnology Index, which contains securities of companies listed on NASDAQ that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals and that also meet other eligibility criteria determined by Nasdaq, Inc. iShares Nasdaq is traded on NASDAQ General Markets in USA. more
NameiShares Nasdaq Biotechnology ETF
ChairmanGeorge ParkerView All
Macroaxis Advice
InstrumentUSA Etf View All
RegionNorth America
Investment IssuerBlackrock
ExchangeNASDAQ General Markets
Etf FamilyBlackrock
Fund CategorySector
Portfolio ConcentrationHealth Care
BenchmarkDOW
Contact Number800 474 2737
CurrencyUSD - US Dollar
IssuerBlackrock
DescriptioniShares Nasdaq Biotechnology ETF
Inception Date2001-02-05
BenchmarkNASDAQ Biotechnology TR USD
Entity TypeRegulated Investment Company
Asset Under Management9.08 Billion
Average Trading Valume2.64 Million
Asset TypeEquity
CategorySector
FocusHealth Care
Market ConcentrationDeveloped Markets
RegionNorth America
AdministratorState Street Bank and Trust Company
AdvisorBlackRock Fund Advisors
CustodianState Street Bank and Trust Company
DistributorBlackRock Investments, LLC
Portfolio ManagerDiane Hsiung, Jennifer Hsui, Greg Savage, Alan Mason
Transfer AgentState Street Bank and Trust Company
Fiscal Year EndMarch 31
ExchangeThe NASDAQ Stock Market LLC
Number of Constituents195
Market MakerVirtu Financial
Total Expense0.47
Management Fee0.47

Diversify with iShares Nasdaq Biotechnology ETF

Build Optimal Portfolios
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add iShares Nasdaq Biotechnology ETF to your portfolio
Please also check Risk vs Return Analysis. Please also try Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.